This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Pulse Biosciences’s 8K filing here.
Pulse Biosciences Company Profile
Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.
Recommended Stories
- Five stocks we like better than Pulse Biosciences
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- The Risks of Owning Bonds
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Differences Between Momentum Investing and Long Term Investing
- Why Amazon Shares May Never Trade Below $200 Again
